|
English
|
正體中文
|
简体中文
|
總筆數 :2853537
|
|
造訪人次 :
45245892
線上人數 :
904
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 551656-551665 / 2346275 (共234628頁) << < 55161 55162 55163 55164 55165 55166 55167 55168 55169 55170 > >> 每頁顯示[10|25|50]項目
| 亞洲大學 |
2015-01 |
Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme
|
Hsieh, 謝佳宏 Chia-Hung |
| 亞洲大學 |
2015/01 |
Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme
|
;Shyu, Woei-Cherng Woei-Cherng; |
| 亞洲大學 |
2015-01 |
Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme
|
Wang, 謝佳宏;Chia-Hung Hsieh ;Yu-Jung Lin;Yu-Jung Lin;Chung-Pu Wu;Chung-Pu Wu;Hsu-Tung Lee;Hsu-Tung Lee;Woei-Cherng;Woei-Cherng Shyu;Chi-Chung Wa;Chi-Chung |
| 亞洲大學 |
2015-01 |
Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme
|
Hsieh)*, 謝佳宏(Chia-Hung;Lin), Yu-Jung Lin(Yu-Jung;Wu), Chung-Pu Wu(Chung-Pu;Lee), Hsu-Tung Lee(Hsu-Tung;Shyu), Woei-Cherng(Woei-Cherng;Wang), Chi-Chung Wa(Chi-Chung |
| 中國醫藥大學 |
2015-01 |
Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme
|
謝佳宏(Chia-Hung Hsieh)*;(Yu-Jung Lin);(Chung-Pu Wu);(Hsu-Tung Lee);徐偉成(Woei-Cherng Shyu)*;(Chi-Chung Wang)* |
| 中國醫藥大學 |
2015-01 |
Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme
|
謝佳宏(Chia-Hung Hsieh)*;(Yu-Jung Lin);(Chung-Pu Wu);(Hsu-Tung Lee);徐偉成(Woei-Cherng Shyu)*;(Chi-Chung Wang)* |
| 高雄醫學大學 |
2009 |
LIVIN, ILP2, BURCE於口腔癌化過程中之表現
|
薛水上;陳遠謙;林立民;陳玉昆 |
| 高雄醫學大學 |
2009 |
LIVIN; ILP2; BURCE於口腔癌化過程中之表現
|
薛水上;陳遠謙;林立民;陳玉昆 |
| 國立臺灣大學 |
2008 |
Living (happily) with contradiction
|
Karen Steffen Chung |
| 國立中山大學 |
2004 |
Living (Rose Bengal Stained) Benthic foraminifera in Sediments off the Southwest Taiwan
|
A.P. Chiang;H.L. Lin;T.C. Lin |
顯示項目 551656-551665 / 2346275 (共234628頁) << < 55161 55162 55163 55164 55165 55166 55167 55168 55169 55170 > >> 每頁顯示[10|25|50]項目
|